‘Outstanding’ and ‘robust’ Mathys & Squire teams ranked in 2022 edition of The Legal 500
Mathys & Squire is pleased to be ranked in the PATMA: Patent Attorneys and PATMA: Trade Mark Attorneys categories in the latest edition of The Legal 500 – the definitive guide to the legal… read more…
World Pharmacists Day 2021: IP in the pharmaceutical industry
Through years of education and hands-on experience with clients, our team of patent and trade mark attorneys have built expertise in all areas of intellectual property (IP) in the pharmaceutical… read more…
Is blockchain patentable? The Australian Patent Office gives an opinion
The number of blockchain patent filings has exploded in recent years at almost every patent office, but as of yet there have been very few decisions on the patentability of blockchain above the… read more…
Mathys & Squire celebrates ‘world-class IP strategists’ in latest IAM Strategy 300 directory
Mathys & Squire is delighted that partners Anna Gregson, Dani Kramer and Martin MacLean have all been identified in the 2021 edition of IAM Strategy 300: The World’s Leading IP… read more…
Mathys & Squire appoints first COO
We are pleased to announce the appointment of Mathys & Squire’s first Chief Operating Officer (COO) in our 111-year history The management board has created the COO role to be responsible for… read more…
Australian Federal Court says an AI can be the inventor
In this article for The Patent Lawyer, partner Jeremy Smith provides an update to his earlier comments regarding the South African patent office issuing the world’s first patent for an invention… read more…
EPO decision T 96/20: Does this raise the inventive step bar for medical use inventions?
The recent decision by the European Patent Office (EPO)’s Technical Board of Appeal 3304 in T 96/20 appears, at first glance, to have raised the bar for acknowledging the inventive step of medical… read more…
South Africa issues world’s first patent naming AI as inventor
In this article written by Intellectual Property Magazine, Mathys & Squire Partner Jeremy Smith provides his commentary in response to the recent news that the South African patent office… read more…
Assessment of inventive step of medical use claims at the EPO: A shift in approach?
At the European Patent Office (EPO), one of the first steps for assessing inventive step of a claim is to determine the closest prior art For medical use claims, the closest prior art is typically… read more…
